Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameLTR PHARMA LIMITEDAnnouncement TypeNew announcementDate of this announcementFriday September 11, 2026The +securities to be quoted are:Total number of...
Application for quotation of securities - LTP
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from LTR Pharma
- Investor Presentation
- LTR Expands Men's Health Portfolio with KYZATREX Pilot
- FY26 Results Announcement
- Appendix 4G and Corporate Governance Statement
- Appendix 4E and Annual Report to Shareholders
Later from LTR Pharma
- Notice of Annual General Meeting/Proxy Form
- SPONTAN Phase II Final Results
- Clinical and Commercial Update - Investor Webinar
- First ROXUS Prescriptions Fulfilled in the United States
- Investor Webinar Presentation
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma